Chen L - Search Results

1

Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.

Xu J, Jia Q, Zhang Y, Yuan Y, Xu T, Yu K, Chai J, Wang K, Chen L, Xiao T, Li M. Xu J, et al. Among authors: chen l. Pathol Res Pract. 2021 Mar;219:153374. doi: 10.1016/j.prp.2021.153374. Epub 2021 Feb 12. Pathol Res Pract. 2021. PMID: 33621918 Review.

2

What are the implications of cost for myeloma therapy?

Xu T, Yang W, Chen L, Gao G. Xu T, et al. Among authors: chen l. Expert Rev Hematol. 2019 Dec;12(12):1005-1009. doi: 10.1080/17474086.2019.1682545. Epub 2019 Oct 31. Expert Rev Hematol. 2019. PMID: 31625767 No abstract available.

3

RSK4: a new prognostic factor in glioma.

Chen L, Xu T, Jia Q, Wang X, Li M, Liang G. Chen L, et al. Pathol Res Pract. 2020 Aug;216(8):153020. doi: 10.1016/j.prp.2020.153020. Epub 2020 May 21. Pathol Res Pract. 2020. PMID: 32703488

4

Tumor necrosis factor-stimulated gene-6-a new serum identification marker to identify severe and symptomatic carotid artery stenosis.

Tian X, Wang X, Shi Z, Yu C, Li M, Chen L, Jia Q, Liang G. Tian X, et al. Among authors: chen l. Pathol Res Pract. 2022 Apr;232:153838. doi: 10.1016/j.prp.2022.153838. Epub 2022 Mar 7. Pathol Res Pract. 2022. PMID: 35278816

5

Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma.

Chai J, Xu T, Yang Y, Yuan Y, Xu J, Liu J, Wang K, Lv Y, Chai J, Kang Y, Chen L, Qin J, Jia Q, Li M. Chai J, et al. Among authors: chen l. Pathol Res Pract. 2022 Apr;232:153841. doi: 10.1016/j.prp.2022.153841. Epub 2022 Mar 11. Pathol Res Pract. 2022. PMID: 35303522

6

UCHL1 promotes cancer stemness in triple-negative breast cancer.

Tian C, Liu Y, Liu Y, Hu P, Xie S, Guo Y, Wang H, Zhang Z, Du L, Lei B, Wang Y, Xue L, Zhang D, Su J, Zhang X, Zhang R, Chen J, Zhang X, Chen L, Li M, Jia Q, Song J, Liu J. Tian C, et al. Among authors: chen j, chen l. Pathol Res Pract. 2022 Dec;240:154235. doi: 10.1016/j.prp.2022.154235. Epub 2022 Nov 21. Pathol Res Pract. 2022. PMID: 36434856

7

Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.

Pang F, Zhang L, Li M, Yi X, Wang Y, Yang P, Wen B, Jiang J, Teng Y, Yang X, Chen L, Xu J, Wang L. Pang F, et al. Among authors: chen l. Cancer Gene Ther. 2023 Dec;30(12):1636-1648. doi: 10.1038/s41417-023-00666-3. Epub 2023 Sep 19. Cancer Gene Ther. 2023. PMID: 37726387

8

O‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway.

Zhai L, Yang X, Dong J, Qian L, Gao Y, Lv Y, Chen L, Chen B, Zhou F. Zhai L, et al. Among authors: chen l, chen b. Int J Oncol. 2023 Aug;63(2):90. doi: 10.3892/ijo.2023.5538. Epub 2023 Jun 23. Int J Oncol. 2023. PMID: 37350405 Free PMC article.

9

Clinical characteristics and prognosis of patients with glioblastoma: A review of survival analysis of 1674 patients based on SEER database.

Chen L, Ma J, Zou Z, Liu H, Liu C, Gong S, Gao X, Liang G. Chen L, et al. Medicine (Baltimore). 2022 Nov 25;101(47):e32042. doi: 10.1097/MD.0000000000032042. Medicine (Baltimore). 2022. PMID: 36451503 Free PMC article. Review.

10

Long non-coding RNA MIR17HG impedes FOSL2-mediated transcription activation of HIC1 to maintain a pro-inflammatory phenotype of microglia during intracerebral haemorrhage.

Ai Y, Kong Y, Zou Z, Chen L, Liang G. Ai Y, et al. Among authors: chen l. Eur J Neurosci. 2023 Nov;58(10):4107-4122. doi: 10.1111/ejn.16163. Epub 2023 Oct 17. Eur J Neurosci. 2023. PMID: 37846812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81,865 results

Search Page